REG - BNP Paribas London Primary Health Props - Form 8.3 - Primary Health Properties plc
31/07/2025 12:00
For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250731:nRSe4313Ta&default-theme=true
RNS Number : 4313T BNP Paribas London 31 July 2025
FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
Rule 8.3 of the Takeover Code (the "Code")
1. KEY INFORMATION
(a) Full name of discloser: BNP Paribas SA
(b) Owner or controller of interests and short positions disclosed, if
different from 1(a):
The naming of nominee or vehicle companies is insufficient. For a
trust, the trustee(s), settlor and beneficiaries must be named.
(c) Name of offeror/offeree in relation to whose relevant securities this form Primary Health Properties plc
relates:
Use a separate form for each offeror/offeree
(d) If an exempt fund manager connected with an offeror/offeree, state this
and specify identity of offeror/offeree:
(e) Date position held/dealing undertaken: 30/07/2025
For an opening position disclosure, state the latest practicable date
prior to the disclosure
(f) In addition to the company in 1(c) above, is the discloser making Yes
disclosures in respect of any other party to the offer?
If YES, specify which:
If it is a cash offer or possible cash offer, state "N/A"
Assura plc
2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE
If there are positions or rights to subscribe to disclose in more than one
class of relevant securities of the offeror or offeree named in 1(c), copy
table 2(a) or (b) (as appropriate) for each additional class of relevant
security.
(a) Interests and short positions in the relevant securities of
the offeror or offeree to which the disclosure relates following the dealing
(if any)
Class of relevant security: GB00BYRJ5J14 (12.5p ordinary)
Interests Short positions
Number % Number %
(1) Relevant securities owned and/or controlled: 3,932,728 0.2943 -2,719,760 -0.2035
(2) Cash-settled derivatives: 2,000,942 0.1497 -741,715 -0.0555
(3) Stock-settled derivatives (including options) and agreements to 0 +0
purchase/sell:
TOTAL: 5,933,670 0.4440 -3,461,475 -0.2590
All interests and all short positions should be disclosed.
Details of any open stock-settled derivative positions (including traded
options), or agreements to purchase or sell relevant securities, should be
given on a Supplemental Form 8 (Open Positions).
(b) Rights to subscribe for new securities (including directors'
and other employee options)
Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:
3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE
Where there have been dealings in more than one class of relevant securities
of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as
appropriate) for each additional class of relevant security dealt in.
The currency of all prices and other monetary amounts should be stated.
(a) Purchases and sales
Class of relevant security Purchase/sale Number of securities Price per unit
GB00BYRJ5J14 Purchase 151 .9585 GBP
GB00BYRJ5J14 Purchase 274 .9590 GBP
GB00BYRJ5J14 Purchase 475 .9595 GBP
GB00BYRJ5J14 Purchase 605 .9571 GBP
GB00BYRJ5J14 Purchase 637 .9600 GBP
GB00BYRJ5J14 Purchase 653 .9590 GBP
GB00BYRJ5J14 Purchase 667 .9565 GBP
GB00BYRJ5J14 Purchase 859 .9560 GBP
GB00BYRJ5J14 Purchase 862 .9603 GBP
GB00BYRJ5J14 Purchase 914 .9565 GBP
GB00BYRJ5J14 Purchase 948 .9565 GBP
GB00BYRJ5J14 Purchase 974 .9570 GBP
GB00BYRJ5J14 Purchase 1,286 .9589 GBP
GB00BYRJ5J14 Purchase 1,347 .9604 GBP
GB00BYRJ5J14 Purchase 1,557 .9605 GBP
GB00BYRJ5J14 Purchase 2,079 .9561 GBP
GB00BYRJ5J14 Purchase 2,174 .9567 GBP
GB00BYRJ5J14 Purchase 2,235 .9565 GBP
GB00BYRJ5J14 Purchase 2,369 .9571 GBP
GB00BYRJ5J14 Purchase 2,534 .9592 GBP
GB00BYRJ5J14 Purchase 2,973 .9578 GBP
GB00BYRJ5J14 Purchase 3,987 .9570 GBP
GB00BYRJ5J14 Purchase 5,555 .9561 GBP
GB00BYRJ5J14 Purchase 8,659 .9567 GBP
GB00BYRJ5J14 Purchase 13,502 .9577 GBP
GB00BYRJ5J14 Purchase 48,042 .9575 GBP
GB00BYRJ5J14 Purchase 81,258 .9585 GBP
GB00BYRJ5J14 Purchase 138,500 .9597 GBP
GB00BYRJ5J14 Purchase 263,403 .9575 GBP
GB00BYRJ5J14 Sale -289,417 .9595 GBP
GB00BYRJ5J14 Sale -218,629 .9575 GBP
GB00BYRJ5J14 Sale -138,500 .9597 GBP
GB00BYRJ5J14 Sale -97,722 .9581 GBP
GB00BYRJ5J14 Sale -95,214 .9595 GBP
GB00BYRJ5J14 Sale -40,049 .9595 GBP
GB00BYRJ5J14 Sale -28,310 .9581 GBP
GB00BYRJ5J14 Sale -11,518 .9595 GBP
GB00BYRJ5J14 Sale -8,659 .9567 GBP
GB00BYRJ5J14 Sale -5,555 .9561 GBP
GB00BYRJ5J14 Sale -3,987 .9570 GBP
GB00BYRJ5J14 Sale -2,973 .9578 GBP
GB00BYRJ5J14 Sale -2,534 .9592 GBP
GB00BYRJ5J14 Sale -2,369 .9571 GBP
GB00BYRJ5J14 Sale -2,235 .9565 GBP
GB00BYRJ5J14 Sale -2,174 .9567 GBP
GB00BYRJ5J14 Sale -2,079 .9561 GBP
GB00BYRJ5J14 Sale -1,557 .9605 GBP
GB00BYRJ5J14 Sale -1,347 .9604 GBP
GB00BYRJ5J14 Sale -1,286 .9589 GBP
GB00BYRJ5J14 Sale -974 .9570 GBP
GB00BYRJ5J14 Sale -948 .9565 GBP
GB00BYRJ5J14 Sale -914 .9565 GBP
GB00BYRJ5J14 Sale -862 .9603 GBP
GB00BYRJ5J14 Sale -859 .9560 GBP
GB00BYRJ5J14 Sale -667 .9565 GBP
GB00BYRJ5J14 Sale -653 .9590 GBP
GB00BYRJ5J14 Sale -637 .9600 GBP
GB00BYRJ5J14 Sale -605 .9571 GBP
GB00BYRJ5J14 Sale -475 .9595 GBP
GB00BYRJ5J14 Sale -274 .9590 GBP
GB00BYRJ5J14 Sale -189 .9595 GBP
GB00BYRJ5J14 Sale -151 .9585 GBP
(b) Cash-settled derivative transactions
Class of relevant security Product description Nature of dealing Number of reference securities Price per unit
e.g. CFD e.g. opening/closing a long/short position, increasing/reducing a long/short
position
GB00BYRJ5J14 Contract for Difference Increasing Long Position 424,680 .9595 GBP
GB00BYRJ5J14 Contract for Difference Increasing Short Position -61,544 .9595 GBP
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type Expiry date Option money paid/ received per unit
e.g. American, European etc.
(ii) Exercise
Class of relevant security Product description Exercising/ exercised against Number of securities Exercise price per unit
e.g. call option
(d) Other dealings (including subscribing for new securities)
Class of relevant security Nature of dealing Details Price per unit (if applicable)
e.g. subscription, conversion
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or
understanding, formal or informal, relating to relevant securities which may
be an inducement to deal or refrain from dealing entered into by the person
making the disclosure and any party to the offer or any person acting in
concert with a party to the offer:
Irrevocable commitments and letters of intent should not be included. If
there are no such agreements, arrangements or understandings, state "none"
none
(b) Agreements, arrangements or understandings relating to
options or derivatives
Details of any agreement, arrangement or understanding, formal or informal,
between the person making the disclosure and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant
securities to which any derivative is referenced:
If there are no such agreements, arrangements or understandings, state "none"
none
(c) Attachments
Is a Supplemental Form 8 (Open Positions) attached? No
Date of disclosure: 31/07/2025
Contact name: Compliance Control Room
Telephone number*: 0207 595 9695
Public disclosures under Rule 8 of the Code must be made to a Regulatory
Information Service.
The Panel's Market Surveillance Unit is available for consultation in relation
to the Code's disclosure requirements on +44 (0)20 7638 0129.
*If the discloser is a natural person, a telephone number does not need to be
included, provided contact information has been provided to the Panel's Market
Surveillance Unit.
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk
(http://www.thetakeoverpanel.org.uk) .
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END RETWPUAAMUPAGUGRecent news on Primary Health Properties
See all newsREG - Primary Health Props - Director/PDMR Shareholding
AnnouncementREG - Primary Health Props - Director Appointment
AnnouncementREG - Primary Health Props - Director/PDMR Shareholding
AnnouncementREG - Competition and Mkts - Merger Update: Primary Health Properties/Assura
AnnouncementREG - Competition and Mkts - Merger Update: PHP/Assura
Announcement